Cancer of Unknown Primary Site, also known as carcinoma of unknown primary origin, is related to x-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome and otofaciocervical syndrome 1. The drugs Ipilimumab and Nivolumab have been mentioned in the context of this disorder. Affiliated tissues include lymph node and thyroid.